Part:BBa K4040015 - parts.igem.org
The QCM frequency shifts of the main steps for the CD19 immobilization... | Download Scientific Diagram
Beads for Research | ProMab
CD19：a validated therapeutic target for B-cell malignancies - ACROBiosystems
Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells: Molecular Therapy Methods & Clinical Development
Cancers | Free Full-Text | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
Human CD19 Magnetic Beads Kit KMS004 | Proteintech
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect
Dynabeads™ CD19 Pan B
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine
CD19 CAR antigen engagement mechanisms and affinity tuning | Science Immunology
Anti-Human CD19 Magnetic Particles - DM
Human CD19 Separation Beads | Biocompare.com Kit/Reagent Review
Enrichment and expansion of anti‐CD19 CAR‐T cells with aAPCs or beads.... | Download Scientific Diagram
FITC Anti-Mouse CD19 (1D3) | Cytek Biosciences
Human CD19 Magnetic Beads MS005 | Proteintech
Anti-Human CD19 Magnetic Particles - DM
Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells
CD19 MicroBeads, human | CD19 Microbeads | human | Products | Miltenyi Biotec | USA
Multiplexing single cell measurement of CAR-T cells in microchambers. a... | Download Scientific Diagram
Anti-CD28 stimulation of CD19-chimeric antigen receptors (CAR) T... | Download Scientific Diagram
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis | BMC Cancer | Full Text
